$ENSG
ENSIGN GROUP, INC Stock $ensg

$ensg Overview Financials Valuation SEC Filings Company Website

2021 Q1 Form 10-Q Financial Statement

#000112537621000077 Filed on April 29, 2021

Income Statement

Concept	2021 Q1	2020 Q1	2019 Q3
Revenue	$627.3M	$589.6M	$512.1M
YoY Change	6.38%	25.1%	-0.44%
Cost Of Revenue	$482.2M	$454.5M	$410.5M
YoY Change	6.09%	22.19%	-0.78%
Gross Profit	$145.1M	$135.1M	$101.6M
YoY Change	7.38%	36.02%	0.95%
Gross Profit Margin	23.13%	22.91%	19.84%
Selling, General & Admin	$71.20M	$67.80M	$60.50M
YoY Change	5.01%	12.44%	145.93%
% of Gross Profit	49.08%	50.19%	59.55%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$13.66M	$13.72M	$13.41M
YoY Change	-0.44%	15.01%	12.63%
% of Gross Profit	9.42%	10.16%	13.19%
Operating Expenses	$84.90M	$81.50M	$73.90M
YoY Change	4.17%	12.88%	102.47%
Operating Profit	$63.68M	$56.79M	$30.80M
YoY Change	12.12%	89.63%	5.16%
Interest Expense	$1.641M	$3.665M	$3.900M
YoY Change	-55.23%	-0.19%	-2.23%
% of Operating Profit	2.58%	6.45%	12.66%
Other Income/Expense, Net	-$893.0K	-$2.967M	-$3.168M
YoY Change	-69.9%	-4.57%	-10.05%
Pretax Income	$62.79M	$53.83M	$27.63M
YoY Change	16.65%	100.54%	7.24%
Income Tax	$12.95M	$12.63M	$5.093M
% Of Pretax Income	20.62%	23.46%	18.43%
Net Earnings	$49.21M	$40.85M	$27.16M
YoY Change	20.46%	49.24%	30.19%
Net Earnings / Revenue	7.84%	6.93%	5.3%
Basic Earnings Per Share	$0.91	$0.76	$0.50
Diluted Earnings Per Share	$0.86	$0.73	$0.48
COMMON SHARES
Basic Shares Outstanding	54.19M shares	53.48M shares	53.94M shares
Diluted Shares Outstanding	56.89M shares	55.80M shares	56.36M shares

Balance Sheet

Concept	2021 Q1	2020 Q1	2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$170.2M	$78.20M	$57.40M
YoY Change	117.65%	86.63%	3.8%
Cash & Equivalents	$155.5M	$63.22M	$44.40M
Short-Term Investments	$14.60M	$15.00M	$13.00M
Other Short-Term Assets	$30.60M	$25.60M	$27.70M
YoY Change	19.53%	5.79%	-12.34%
Inventory
Prepaid Expenses
Receivables	$312.6M	$329.5M	$308.1M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$513.3M	$433.3M	$393.2M
YoY Change	18.46%	21.13%	12.85%
LONG-TERM ASSETS
Property, Plant & Equipment	$779.3M	$783.3M	$708.2M
YoY Change	-0.51%	24.85%	19.41%
Goodwill	$54.47M	$54.47M	$96.20M
YoY Change	0.0%	-37.44%	22.37%
Intangibles
YoY Change
Long-Term Investments	$34.40M	$32.90M	$34.60M
YoY Change	4.56%	-23.31%	6.46%
Other Assets	$74.20M	$33.80M	$25.40M
YoY Change	119.53%	105.58%	24.15%
Total Long-Term Assets	$1.999B	$1.955B	$1.966B
YoY Change	2.28%	6.22%	147.29%
TOTAL ASSETS
Total Short-Term Assets	$513.3M	$433.3M	$393.2M
Total Long-Term Assets	$1.999B	$1.955B	$1.966B
Total Assets	$2.513B	$2.388B	$2.360B
YoY Change	5.21%	8.65%	106.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$53.94M	$40.92M	$40.02M
YoY Change	31.83%	-8.25%	-3.16%
Accrued Expenses	$365.4M	$265.1M	$283.6M
YoY Change	37.83%	10.37%	59.24%
Deferred Revenue	$6.049M	$6.173M	$10.16M
YoY Change	-2.01%	-14.49%	9.54%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.828M	$2.727M	$10.18M
YoY Change	3.7%	-73.08%	0.96%
Total Short-Term Liabilities	$443.0M	$330.1M	$354.6M
YoY Change	34.19%	6.0%	43.08%
LONG-TERM LIABILITIES
Long-Term Debt	$111.9M	$344.6M	$265.7M
YoY Change	-67.53%	43.19%	8.18%
Other Long-Term Liabilities	$11.12M	$8.647M	$13.76M
YoY Change	28.56%	-30.8%	27.38%
Total Long-Term Liabilities	$11.12M	$8.647M	$13.76M
YoY Change	28.56%	-96.58%	-94.64%
TOTAL LIABILITIES
Total Short-Term Liabilities	$443.0M	$330.1M	$354.6M
Total Long-Term Liabilities	$11.12M	$8.647M	$13.76M
Total Liabilities	$1.637B	$1.711B	$1.658B
YoY Change	-4.34%	7.86%	190.22%
SHAREHOLDERS EQUITY
Retained Earnings	$597.4M	$429.7M	$426.4M
YoY Change	39.02%	13.54%	32.65%
Common Stock	$349.9M	$315.8M	$303.7M
YoY Change	10.78%	7.92%	8.92%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$71.22M	$70.30M	$43.89M
YoY Change	1.32%	83.04%	14.28%
Treasury Stock Shares	2.791M shares	2.771M shares	2.046M shares
Shareholders Equity	$876.0M	$675.2M	$686.3M
YoY Change
Total Liabilities & Shareholders Equity	$2.513B	$2.388B	$2.360B
YoY Change	5.21%	7.65%	106.33%

Cashflow Statement

Concept	2021 Q1	2020 Q1	2019 Q3
OPERATING ACTIVITIES
Net Income	$49.21M	$40.85M	$27.16M
YoY Change	20.46%	49.24%	30.19%
Depreciation, Depletion And Amortization	$13.66M	$13.72M	$13.41M
YoY Change	-0.44%	15.01%	12.63%
Cash From Operating Activities	$34.29M	$27.12M	$65.30M
YoY Change	26.44%	36.94%	16.4%
INVESTING ACTIVITIES
Capital Expenditures	-$15.30M	-$29.90M	-$49.90M
YoY Change	-48.83%	-319.13%	217.83%
Acquisitions	$0.00	$0.00
YoY Change		-100.0%
Other Investing Activities	$279.0K	$237.0K	-$1.200M
YoY Change	17.72%	59.06%	-175.0%
Cash From Investing Activities	-$12.21M	-$15.54M	-$51.20M
YoY Change	-21.43%	-23.65%	263.12%
FINANCING ACTIVITIES
Cash Dividend Paid	$2.868M	$2.705M
YoY Change	6.03%	7.13%
Common Stock Issuance & Retirement, Net	$0.00	$25.00M
YoY Change	-100.0%
Debt Paid & Issued, Net	$849.0K	$240.7M
YoY Change	-99.65%	-6.54%
Cash From Financing Activities	-$103.1M	-$7.539M	-8.800M
YoY Change	1267.78%	-203.39%	-62.71%
NET CHANGE
Cash From Operating Activities	$34.29M	$27.12M	65.30M
Cash From Investing Activities	-$12.21M	-$15.54M	-51.20M
Cash From Financing Activities	-$103.1M	-$7.539M	-8.800M
Net Change In Cash	-$81.04M	$4.042M	5.300M
YoY Change	-2104.82%	-40.04%	-71.2%
FREE CASH FLOW
Cash From Operating Activities	$34.29M	$27.12M	$65.30M
Capital Expenditures	-$15.30M	-$29.90M	-$49.90M
Free Cash Flow	$49.59M	$57.02M	$115.2M
YoY Change	-13.03%	825.55%	60.45%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001125376
CY2021Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2021Q1	dei	Amendment Flag AmendmentFlag	false
CY2021Q1	dei	Document Type DocumentType	10-Q
CY2021Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2021Q1	dei	Entity File Number EntityFileNumber	001-33757
CY2021Q1	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	54977473	shares
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	155527000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	236562000	USD
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	11090000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	8718000	USD
CY2021Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	312578000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	305062000	USD
CY2021Q1	us-gaap	Short Term Investments ShortTermInvestments	14623000	USD
CY2020Q4	us-gaap	Short Term Investments ShortTermInvestments	13449000	USD
CY2021Q1	us-gaap	Prepaid Taxes PrepaidTaxes	0	USD
CY2020Q4	us-gaap	Prepaid Taxes PrepaidTaxes	1224000	USD
CY2021Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	30588000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	26659000	USD
CY2021Q1	us-gaap	Assets Current AssetsCurrent	513316000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	582956000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	779269000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	778244000	USD
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1050506000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1025510000	USD
CY2021Q1	ensg	Insurance Subsidiary Deposits And Investments InsuranceSubsidiaryDepositsAndInvestments	34370000	USD
CY2020Q4	ensg	Insurance Subsidiary Deposits And Investments InsuranceSubsidiaryDepositsAndInvestments	32105000	USD
CY2021Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	350000	USD
CY2020Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	100000	USD
CY2021Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	32424000	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	32424000	USD
CY2021Q1	us-gaap	Other Restricted Assets Noncurrent OtherRestrictedAssetsNoncurrent	41422000	USD
CY2020Q4	us-gaap	Other Restricted Assets Noncurrent OtherRestrictedAssetsNoncurrent	33155000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2828000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2899000	USD
CY2021Q1	us-gaap	Goodwill Goodwill	54469000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	54469000	USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2021Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	3546000	USD
CY2020Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	3716000	USD
CY2021Q1	us-gaap	Assets Assets	2512500000	USD
CY2020Q4	us-gaap	Assets Assets	2545578000	USD
CY2021Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	53942000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	50901000	USD
CY2021Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	203420000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	236614000	USD
CY2021Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	50056000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	48187000	USD
CY2021Q1	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	35135000	USD
CY2020Q4	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	34396000	USD
CY2021Q1	ensg	Covid Liabilities Current COVIDLiabilitiesCurrent	0	USD
CY2020Q4	ensg	Covid Liabilities Current COVIDLiabilitiesCurrent	102023000	USD
CY2021Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	97639000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	87318000	USD
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	57744000	shares
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	54953000	shares
CY2021Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	2828000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	2960000	USD
CY2021Q1	us-gaap	Liabilities Current LiabilitiesCurrent	443020000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	562399000	USD
CY2021Q1	ensg	Long Term Debt Net Of Current Maturities And Debt Discount LongTermDebtNetOfCurrentMaturitiesAndDebtDiscount	111859000	USD
CY2020Q4	ensg	Long Term Debt Net Of Current Maturities And Debt Discount LongTermDebtNetOfCurrentMaturitiesAndDebtDiscount	112544000	USD
CY2021Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	973679000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	950320000	USD
CY2021Q1	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	66742000	USD
CY2020Q4	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	62402000	USD
CY2021Q1	ensg	Deferred Rent And Other Long Term Liabilities DeferredRentAndOtherLongTermLiabilities	41620000	USD
CY2020Q4	ensg	Deferred Rent And Other Long Term Liabilities DeferredRentAndOtherLongTermLiabilities	39686000	USD
CY2021Q1	us-gaap	Liabilities Liabilities	1636920000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	1727351000	USD
CY2021Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q1	dei	Entity Registrant Name EntityRegistrantName	ENSIGN GROUP, INC
CY2021Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	33-0861263
CY2021Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	29222 Rancho Viejo Road, Suite 127
CY2021Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	San Juan Capistrano
CY2021Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2021Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92675
CY2021Q1	dei	City Area Code CityAreaCode	949
CY2021Q1	dei	Local Phone Number LocalPhoneNumber	487-9500
CY2021Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
CY2021Q1	dei	Trading Symbol TradingSymbol	ENSG
CY2021Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2021Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2021Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2021Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	57417000	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	54626000	shares
CY2021Q1	us-gaap	Common Stock Value CommonStockValue	58000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	58000	USD
CY2021Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	349836000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	338177000	USD
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	597375000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	551055000	USD
CY2020Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	2791000	shares
CY2021Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	2791000	shares
CY2021Q1	us-gaap	Treasury Stock Value TreasuryStockValue	71222000	USD
CY2020Q4	us-gaap	Treasury Stock Value TreasuryStockValue	71213000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	876047000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	818077000	USD
CY2021Q1	us-gaap	Minority Interest MinorityInterest	-467000	USD
CY2020Q4	us-gaap	Minority Interest MinorityInterest	150000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	49206000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	40849000	USD
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.91
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	875580000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	818227000	USD
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2512500000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2545578000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	627253000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	589613000	USD
CY2021Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	482186000	USD
CY2020Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	454521000	USD
CY2021Q1	ensg	Rent Costof Services RentCostofServices	33456000	USD
CY2020Q1	ensg	Rent Costof Services RentCostofServices	32330000	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	34273000	USD
CY2020Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	32249000	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	13659000	USD
CY2020Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	13720000	USD
CY2021Q1	us-gaap	Costs And Expenses CostsAndExpenses	563574000	USD
CY2020Q1	us-gaap	Costs And Expenses CostsAndExpenses	532820000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	63679000	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	56793000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	1641000	USD
CY2020Q1	us-gaap	Interest Expense InterestExpense	3665000	USD
CY2021Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	748000	USD
CY2020Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	698000	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-893000	USD
CY2020Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2967000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	62786000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	53826000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	12949000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	12625000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	49837000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	41201000	USD
CY2021Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	631000	USD
CY2020Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	352000	USD
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.76
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.86
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.73
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	54192000	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	53475000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	56891000	shares
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	55796000	shares
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	818227000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3880000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	3725000	USD
CY2021Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	9000	USD
CY2020Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.0525
CY2021Q1	us-gaap	Dividends Dividends	2886000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4054000	USD
CY2021Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	631000	USD
CY2021Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	1248000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	49206000	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	875580000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	656144000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1552000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	3086000	USD
CY2019Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.0500
CY2020Q1	us-gaap	Dividends Dividends	2683000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3235000	USD
CY2020Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	25000000	USD
CY2020Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	352000	USD
CY2020Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	720000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	40849000	USD
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	676815000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	49837000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	41201000	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	13659000	USD
CY2020Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	13720000	USD
CY2021Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	210000	USD
CY2020Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	210000	USD
CY2021Q1	ensg	Non Cash Lease Expense NonCashLeaseExpense	112000	USD
CY2020Q1	ensg	Non Cash Lease Expense NonCashLeaseExpense	125000	USD
CY2021Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2020Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1003000	USD
CY2021Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2560000	USD
CY2020Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1312000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	4054000	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3235000	USD
CY2021Q1	ensg	Gain Loss On Other Assets GainLossOnOtherAssets	236000	USD
CY2020Q1	ensg	Gain Loss On Other Assets GainLossOnOtherAssets	-101000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	15449000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	21845000	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	-1224000	USD
CY2020Q1	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	-739000	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4271000	USD
CY2020Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1589000	USD
CY2021Q1	us-gaap	Life Insurance Corporate Or Bank Owned Change In Value LifeInsuranceCorporateOrBankOwnedChangeInValue	7440000	USD
CY2020Q1	us-gaap	Life Insurance Corporate Or Bank Owned Change In Value LifeInsuranceCorporateOrBankOwnedChangeInValue	3712000	USD
CY2021Q1	ensg	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-133000	USD
CY2020Q1	ensg	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-181000	USD
CY2021Q1	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	7459000	USD
CY2020Q1	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	3660000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2768000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-3257000	USD
CY2021Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-34562000	USD
CY2020Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-16381000	USD
CY2021Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	11791000	USD
CY2020Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	10882000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-1737000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-4040000	USD
CY2021Q1	us-gaap	Increase Decrease In Self Insurance Reserve IncreaseDecreaseInSelfInsuranceReserve	4615000	USD
CY2020Q1	us-gaap	Increase Decrease In Self Insurance Reserve IncreaseDecreaseInSelfInsuranceReserve	1985000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	-167000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	-45000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	34294000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	27123000	USD
CY2021Q1	ensg	Payments To Acquire Property And Equipment PaymentsToAcquirePropertyAndEquipment	15334000	USD
CY2020Q1	ensg	Payments To Acquire Property And Equipment PaymentsToAcquirePropertyAndEquipment	15810000	USD
CY2021Q1	ensg	Payments To Acquire Asset Acquisitions PaymentsToAcquireAssetAcquisitions	0	USD
CY2020Q1	ensg	Payments To Acquire Asset Acquisitions PaymentsToAcquireAssetAcquisitions	14054000	USD
CY2021Q1	us-gaap	Payments For Deposits On Real Estate Acquisitions PaymentsForDepositsOnRealEstateAcquisitions	250000	USD
CY2020Q1	us-gaap	Payments For Deposits On Real Estate Acquisitions PaymentsForDepositsOnRealEstateAcquisitions	0	USD
CY2021Q1	us-gaap	Proceeds From Deposits On Real Estate Sales ProceedsFromDepositsOnRealEstateSales	0	USD
CY2020Q1	us-gaap	Proceeds From Deposits On Real Estate Sales ProceedsFromDepositsOnRealEstateSales	14050000	USD
CY2021Q1	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	6250000	USD
CY2020Q1	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	0	USD
CY2021Q1	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	840000	USD
CY2020Q1	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	121000	USD
CY2021Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	6869000	USD
CY2020Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	1008000	USD
CY2021Q1	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	3430000	USD
CY2020Q1	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	1396000	USD
CY2021Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	279000	USD
CY2020Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	237000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-12212000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-15542000	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	0	USD
CY2020Q1	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	260000000	USD
CY2021Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	849000	USD
CY2020Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	240666000	USD
CY2021Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3880000	USD
CY2020Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1552000	USD
CY2021Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	9000	USD
CY2020Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
CY2021Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2020Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	25000000	USD
CY2021Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	2868000	USD
CY2020Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	2705000	USD
CY2021Q1	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	-1248000	USD
CY2020Q1	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	-720000	USD
CY2021Q1	ensg	Proceeds From Cares Act Provider Relief Funds And Medicare Advance Payment Program ProceedsFromCARESActProviderReliefFundsAndMedicareAdvancePaymentProgram	9139000	USD
CY2020Q1	ensg	Proceeds From Cares Act Provider Relief Funds And Medicare Advance Payment Program ProceedsFromCARESActProviderReliefFundsAndMedicareAdvancePaymentProgram	0	USD
CY2021Q1	ensg	Coronavirus Aid Relief And Economic Security Cares Funds Repaid CoronavirusAidReliefAndEconomicSecurityCARESFundsRepaid	111162000	USD
CY2020Q1	ensg	Coronavirus Aid Relief And Economic Security Cares Funds Repaid CoronavirusAidReliefAndEconomicSecurityCARESFundsRepaid	0	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-103117000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-7539000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-81035000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	4042000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	236562000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	59175000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	155527000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	63217000	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	1427000	USD
CY2020Q1	us-gaap	Interest Paid Net InterestPaidNet	4835000	USD
CY2021Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	33339000	USD
CY2020Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	32481000	USD
CY2021Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	3800000	USD
CY2020Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	3300000	USD
CY2021Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	2886000	USD
CY2020Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	2683000	USD
CY2021Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	37471000	USD
CY2020Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	8370000	USD
CY2020Q4	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	7138000	USD
CY2021Q1	ensg	Number Of Health Care Facilities NumberOfHealthCareFacilities	232	facility
CY2021Q1	ensg	Operational Skilled Nursing Beds OperationalSkilledNursingBeds	23600	bed
CY2021Q1	ensg	Operational Senior Living Units OperationalSeniorLivingUnits	2200	bed
CY2021Q1	ensg	Number Of Real Estate Properties Leased NumberOfRealEstatePropertiesLeased	168	facility
CY2021Q1	ensg	Number Of Real Estate Properties Leased With Option To Purchase NumberOfRealEstatePropertiesLeasedWithOptionToPurchase	11	facility
CY2021Q1	ensg	Number Of Real Estate Properties Leased NumberOfRealEstatePropertiesLeased	168	facility
CY2021Q1	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	94	facility
CY2021Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2021Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> — </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior period results have been reclassified to be consistent with the current period presentation. Prior period results also reflect reclassifications, for comparative purposes, related to the change in the Company's segment structure. Refer to Note 7, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Segments</span>, for additional information related to segments. Prior to the fourth quarter of 2020, the Company only presented total revenue for all revenue services. As a result of the change in segments, the presentation of the Company's service revenue and rental revenue are presented separately on the Company's Condensed Consolidated Statements of Income. The reclassifications had no effect on the reported condensed consolidated results of operations.
CY2021Q1	us-gaap	Use Of Estimates UseOfEstimates	<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Estimates and Assumptions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> —</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The preparation of Interim Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Interim Financial Statements and the reported amounts of revenue and expenses during the reporting periods. The most significant estimates in the Company’s Interim Financial Statements relate to revenue, acquired property and equipment, intangible assets and goodwill, right-of-use-assets, impairment of long-lived assets, lease liabilities, general and professional liabilities, workers' compensation and healthcare claims included in accrued self-insurance liabilities, and income taxes. Actual results could differ from those estimates.</span>
CY2020Q1	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	USD
CY2021Q1	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	USD
CY2020Q1	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
CY2021Q1	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
CY2021Q1	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	7602000	USD
CY2021Q1	ensg	Coronavirus Aid Relief And Economic Security Cares Funds Received CoronavirusAidReliefAndEconomicSecurityCARESFundsReceived	9139000	USD
CY2021Q1	ensg	Medicare Accelerated And Advance Payment Caresact MedicareAcceleratedAndAdvancePaymentCARESACT	105255000	USD
CY2020Q3	ensg	Repayment Of Funds Received From The Medicare Accelerated And Advance Payment Program Cares Act RepaymentOfFundsReceivedFromTheMedicareAcceleratedAndAdvancePaymentProgramCARESAct	3232000	USD
CY2021Q1	ensg	Repayment Of Funds Received From The Medicare Accelerated And Advance Payment Program Cares Act RepaymentOfFundsReceivedFromTheMedicareAcceleratedAndAdvancePaymentProgramCARESAct	102023000	USD
CY2020Q4	ensg	Accrued Liabilities State Relief Contract Liabilities AccruedLiabilitiesStateReliefContractLiabilities	6520000	USD
CY2021Q1	ensg	Family First Coronavirus Response Act Payments Received FamilyFirstCoronavirusResponseActPaymentsReceived	15645000	USD
CY2021Q1	ensg	Revenue Family First Coronavirus Response Act Payments Received RevenueFamilyFirstCoronavirusResponseActPaymentsReceived	16465000	USD
CY2020Q1	ensg	Family First Coronavirus Response Act Payments Received FamilyFirstCoronavirusResponseActPaymentsReceived	730000	USD
CY2021Q1	ensg	Liabilities Deferred Tax Payments Under Cares Act LiabilitiesDeferredTaxPaymentsUnderCARESAct	48309000	USD
CY2021Q1	ensg	Liabilities Deferred Tax Payments Under Cares Act Current LiabilitiesDeferredTaxPaymentsUnderCARESActCurrent	24155000	USD
CY2021Q1	ensg	Liabilities Deferred Tax Payments Under Cares Act Noncurrent LiabilitiesDeferredTaxPaymentsUnderCARESActNoncurrent	24154000	USD
CY2021Q1	us-gaap	Accounts Receivable Gross AccountsReceivableGross	323668000	USD
CY2020Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	313780000	USD
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	11090000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	8718000	USD
CY2021Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	312578000	USD
CY2020Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	305062000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	49837000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	41201000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	631000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	352000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	49206000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	40849000	USD
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	54192000	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	53475000	shares
CY2021Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.91
CY2020Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.76
CY2021Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	49837000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	41201000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	631000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	352000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	49206000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	40849000	USD
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	54192000	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	53475000	shares
CY2021Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2699000	shares
CY2020Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2321000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	56891000	shares
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	55796000	shares
CY2021Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.86
CY2020Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.73
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	28000	shares
CY2020Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	787000	shares
CY2021Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2021Q1	ensg	Transitional And Skilled Service Facilities TransitionalAndSkilledServiceFacilities	200	facility
CY2021Q1	ensg	Transitional And Skilled Services And Senior Living Campuses TransitionalAndSkilledServicesAndSeniorLivingCampuses	23	facility
CY2021Q1	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	94	facility
CY2021Q1	ensg	Senior Living Facilities SeniorLivingFacilities	9	facility
CY2021Q1	ensg	Transitional And Skilled Services And Senior Living Campuses TransitionalAndSkilledServicesAndSeniorLivingCampuses	23	facility
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	627253000	USD
CY2021Q1	ensg	Segment Income Loss SegmentIncomeLoss	62346000	USD
CY2021Q1	us-gaap	Profit Loss From Real Estate Operations ProfitLossFromRealEstateOperations	440000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	62786000	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	13659000	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-893000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	589613000	USD
CY2020Q1	ensg	Segment Income Loss SegmentIncomeLoss	53826000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	53826000	USD
CY2020Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	13720000	USD
CY2020Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2967000	USD
CY2020Q1	ensg	Payments To Acquire Business And Asset Acquisitions PaymentsToAcquireBusinessAndAssetAcquisitions	14054000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1040785000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1027249000	USD
CY2021Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	261516000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	249005000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	779269000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	778244000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	5354000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2526000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2828000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	5412000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2513000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2899000	USD
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	361000	USD
CY2020Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	674000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	176000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	234000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	234000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	234000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	234000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	234000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2828000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	1482000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	54469000	USD
CY2021Q1	us-gaap	Goodwill Goodwill	54469000	USD
CY2021Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	3546000	USD
CY2020Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	3716000	USD
CY2021Q1	us-gaap	Debt Issuance Costs Line Of Credit Arrangements Net DebtIssuanceCostsLineOfCreditArrangementsNet	2486000	USD
CY2020Q4	us-gaap	Debt Issuance Costs Line Of Credit Arrangements Net DebtIssuanceCostsLineOfCreditArrangementsNet	2664000	USD
CY2021Q1	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	7602000	USD
CY2020Q4	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	7138000	USD
CY2021Q1	us-gaap	Security Deposit SecurityDeposit	12637000	USD
CY2020Q4	us-gaap	Security Deposit SecurityDeposit	12400000	USD
CY2021Q1	us-gaap	Other Restricted Assets OtherRestrictedAssets	4680000	USD
CY2020Q4	us-gaap	Other Restricted Assets OtherRestrictedAssets	4376000	USD
CY2021Q1	us-gaap	Cash Surrender Value Of Life Insurance CashSurrenderValueOfLifeInsurance	14017000	USD
CY2020Q4	us-gaap	Cash Surrender Value Of Life Insurance CashSurrenderValueOfLifeInsurance	6577000	USD
CY2021Q1	us-gaap	Other Restricted Assets Noncurrent OtherRestrictedAssetsNoncurrent	41422000	USD
CY2020Q4	us-gaap	Other Restricted Assets Noncurrent OtherRestrictedAssetsNoncurrent	33155000	USD
CY2021Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	306000	USD
CY2021Q1	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	351000	USD
CY2020Q1	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	87000	USD
CY2021Q1	ensg	Quality Assurance Fee QualityAssuranceFee	7103000	USD
CY2020Q4	ensg	Quality Assurance Fee QualityAssuranceFee	6631000	USD
CY2021Q1	ensg	Resident Refunds Payable ResidentRefundsPayable	39590000	USD
CY2020Q4	ensg	Resident Refunds Payable ResidentRefundsPayable	36323000	USD
CY2021Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	6049000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	8558000	USD
CY2021Q1	ensg	Accrued Liabilities State Relief Contract Liabilities AccruedLiabilitiesStateReliefContractLiabilities	5700000	USD
CY2020Q4	ensg	Accrued Liabilities State Relief Contract Liabilities AccruedLiabilitiesStateReliefContractLiabilities	6520000	USD
CY2021Q1	ensg	Cash Held In Trust For Residents CashHeldInTrustForResidents	5611000	USD
CY2020Q4	ensg	Cash Held In Trust For Residents CashHeldInTrustForResidents	6052000	USD
CY2021Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	2886000	USD
CY2020Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	2868000	USD
CY2021Q1	us-gaap	Accrual For Taxes Other Than Income Taxes Current And Noncurrent AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent	7656000	USD
CY2020Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current And Noncurrent AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent	9222000	USD
CY2021Q1	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	11927000	USD
CY2020Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	136000	USD
CY2021Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	11117000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	11008000	USD
CY2021Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	97639000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	87318000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	12949000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	12625000	USD
CY2021Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.206
CY2020Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.235
CY2021Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	2828000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	2960000	USD
CY2021Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	2270000	USD
CY2020Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	2302000	USD
CY2021Q1	ensg	Long Term Debt Net Of Current Maturities And Debt Discount LongTermDebtNetOfCurrentMaturitiesAndDebtDiscount	111859000	USD
CY2020Q4	ensg	Long Term Debt Net Of Current Maturities And Debt Discount LongTermDebtNetOfCurrentMaturitiesAndDebtDiscount	112544000	USD
CY2021Q1	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	7580000	USD
CY2021Q1	ensg	Number Of Option Plans NumberOfOptionPlans	1	plan
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	136000	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	136000	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.008
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M18D
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.422
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.002
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	145000	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.013
CY2020Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y2M12D
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.321
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.004
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	136000	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	83.64
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	33.99
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	145000	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	51.20
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	16.60
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue	0
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue	0
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4038000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	27.71
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	2148000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	16.66
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	136000	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	83.64
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	33000	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	41.27
CY2021Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	246000	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	15.78
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3895000	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	30.30
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	2034000	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	17.73
CY2021Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	3895000	shares
CY2021Q1	ensg	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Fair Value ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue	44151000	USD
CY2021Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	2034000	shares
CY2021Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	90000	shares
CY2020Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	113000	shares
CY2021Q1	ensg	Sharebased Compensation Restricted Awards Exercise Price SharebasedCompensationRestrictedAwardsExercisePrice	0
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P5Y
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	591000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	38.90
CY2021Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	90000	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	83.71
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	80000	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	64.35
CY2021Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited	9000	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	45.18
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	592000	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	42.16
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4054000	USD
CY2020Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3235000	USD
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y1M6D
CY2021Q1	ensg	Facilities Under Master Lease Arrangement FacilitiesUnderMasterLeaseArrangement	40	facility
CY2021Q1	ensg	Master Lease Agreements MasterLeaseAgreements	7	agreement
CY2021Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	37209000	USD
CY2020Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	35912000	USD
CY2021Q1	ensg	Deferred Rent Adjustment DeferredRentAdjustment	112000	USD
CY2020Q1	ensg	Deferred Rent Adjustment DeferredRentAdjustment	125000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	98448000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	131211000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	129521000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	128600000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	128506000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	128383000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	957340000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1702009000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	678274000	USD
CY2021Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	1023735000	USD
CY2021Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	50056000	USD
CY2021Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	973679000	USD
CY2021Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P13Y8M12D
CY2021Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.082
CY2021Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	3977000	USD
CY2020Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	3662000	USD
CY2021Q1	us-gaap	Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear	11671000	USD
CY2021Q1	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	15053000	USD
CY2021Q1	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	14790000	USD
CY2021Q1	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	14170000	USD
CY2021Q1	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	13952000	USD
CY2021Q1	us-gaap	Lessor Operating Lease Payments To Be Received Five Years LessorOperatingLeasePaymentsToBeReceivedFiveYears	13772000	USD
CY2021Q1	us-gaap	Lessor Operating Lease Payments To Be Received Thereafter LessorOperatingLeasePaymentsToBeReceivedThereafter	85281000	USD
CY2021Q1	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	168689000	USD
CY2021Q1	ensg	Facilities Under Medicare Probe Reviews FacilitiesUnderMedicareProbeReviews	2	facility
CY2020Q1	ensg	Number Of Stock Repurchase Programs NumberOfStockRepurchasePrograms	2	numberOfRepurchasePrograms
CY2020Q1	ensg	Number Of Stock Repurchase Programs NumberOfStockRepurchasePrograms	2	numberOfRepurchasePrograms

Files In Submission

Name	View Source	Status
0001125376-21-000077-index-headers.html	Edgar Link	pending
0001125376-21-000077-index.html	Edgar Link	pending
0001125376-21-000077.txt	Edgar Link	pending
0001125376-21-000077-xbrl.zip	Edgar Link	pending
ensg-20210331.htm	Edgar Link	pending
ensg-20210331.xsd	Edgar Link	pending
ensg-20210331_cal.xml	Edgar Link	unprocessable
ensg-20210331_def.xml	Edgar Link	unprocessable
ensg-20210331_g1.jpg	Edgar Link	pending
ensg-20210331_htm.xml	Edgar Link	completed
ensg-20210331_lab.xml	Edgar Link	unprocessable
ensg-20210331_pre.xml	Edgar Link	unprocessable
ensgq12021ex311.htm	Edgar Link	pending
ensgq12021ex312.htm	Edgar Link	pending
ensgq12021ex321.htm	Edgar Link	pending
ensgq12021ex322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ENSG
ENSIGN GROUP, INC Stock $ensg

2021 Q1 Form 10-Q Financial Statement

#000112537621000077 Filed on April 29, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ENSG ENSIGN GROUP, INC Stock $ensg

2021 Q1 Form 10-Q Financial Statement

#000112537621000077 Filed on April 29, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ENSG
ENSIGN GROUP, INC Stock $ensg